Identifies genetic connections among autoimmune diseases, suggesting targets for drug repurposing.
By integrating GWAS and multi-omics data, our study delineates the genetic and regulatory architecture underlying autoimmunity, suggesting potential therapeutic targets and opportunities for drug repurposing.
No takes yet. Share an insight, caveat, or question.
Dang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: